“…Recently, Agapios Sachinidis and colleagues from the University of Cologne published a review about possibilities and limitations of stem cell-based test methods in pharmacology and toxicology (Sachinidis et al, 2019[ 18 ]). In recent years, much progress has been achieved concerning in vitro techniques of liver (Godoy et al, 2013[ 7 ]; Grinberg et al, 2014[ 10 ]; Leist et al, 2017[ 15 ]; Ghallab et al, 2016[ 6 ]), kidney (Sjögren et al, 2018[ 24 ]; Jiang et al, 2018[ 11 ]; Su et al, 2016[ 25 ]; Valente et al, 2012[ 26 ]; Lee et al, 2017[ 14 ]), neuronal (Keil et al, 2018[ 12 ]; Yang et al, 2018[ 28 ]; Colaianna et al, 2017[ 5 ]; Sisnaiske et al, 2014[ 23 ]) and developmental toxicity (Adam et al, 2019[ 2 ]; Bridges et al, 2019[ 3 ]; Abbott, 2019[ 1 ]). Particularly, in developmental and reproductive toxicity testing, large numbers of animals are needed for analysis of a single compound (Krug et al, 2013[ 13 ]).…”